{"product_id":"global-biologics-safety-testing-market-growth-status-and-outlook-2023-2029","title":"Global Biologics Safety Testing Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Biologics Safety Testing Market Growth (Status and Outlook) 2023-2029\u003cbr\u003e\nLPI (LP Information)' newest research report, the “Biologics Safety Testing Industry Forecast” looks at past sales and reviews total world Biologics Safety Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Biologics Safety Testing sales for 2023 through 2029. With Biologics Safety Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologics Safety Testing industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global Biologics Safety Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Biologics Safety Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biologics Safety Testing market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologics Safety Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologics Safety Testing.\u003c\/p\u003e\n\n\u003cp\u003eThe global Biologics Safety Testing market size is projected to grow from US$ 2413.8 million in 2022 to US$ 3935.9 million in 2029; it is expected to grow at a CAGR of 7.2% from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eBiologics are advanced drugs used in treatment of cancer, rheumatoid arthritis, and other diseases. These biologics constitutes large molecules such as monoclonal antibodies, recombinant proteins and their safety ensures patient safety as these are used in the treatment of different diseases.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of Biologics Safety Testing market by product type, application, key players and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003cbr\u003e\nEndotoxin Tests\u003cbr\u003e\nSterility Tests\u003cbr\u003e\nCell Line Authentication and Characterization Tests\u003cbr\u003e\nBioburden Tests\u003cbr\u003e\nCell Line Authentication\u003cbr\u003e\nResidual Host Contaminant Detection Tests\u003cbr\u003e\nAdventitious Agent Detection Tests\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003cbr\u003e\nPharmaceutical\u003cbr\u003e\nMedical Research\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003cbr\u003e\nAmericas\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nMexico\u003cbr\u003e\nBrazil\u003cbr\u003e\nAPAC\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nKorea\u003cbr\u003e\nSoutheast Asia\u003cbr\u003e\nIndia\u003cbr\u003e\nAustralia\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUK\u003cbr\u003e\nItaly\u003cbr\u003e\nRussia\u003cbr\u003e\nMiddle East \u0026amp; Africa\u003cbr\u003e\nEgypt\u003cbr\u003e\nSouth Africa\u003cbr\u003e\nIsrael\u003cbr\u003e\nTurkey\u003cbr\u003e\nGCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\nLonza Group\u003cbr\u003e\nCharles River\u003cbr\u003e\nMerck\u003cbr\u003e\nSGS\u003cbr\u003e\nWuXi AppTec\u003cbr\u003e\nThermo Fisher Scientific\u003cbr\u003e\nSartorius\u003cbr\u003e\nCytovance Biologics\u003cbr\u003e\nPace Analytical Services\u003cbr\u003e\nToxikon\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"February, 2023 \/ 102 Pages \/ MCW16227525","offer_id":47645970137394,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-biologics-safety-testing-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}